TearClear is an ophthalmic pharmaceutical company that specializes in developing preservative-free drug delivery systems for patients with chronic eye disease and ocular surface disease. With a focus on transforming trusted drugs into best-in-class therapies, TearClear is at the forefront of innovation in the field of ophthalmology. Their lead candidates in glaucoma treatment are just the beginning, as TearClear is actively working on expanding their programs to cover other indications.

By eliminating the use of preservatives before delivery, while still maintaining sterility within the bottle, TearClear's technology offers a unique and compelling solution to a long-standing problem in the field. Renowned experts in the field of ophthalmology have praised TearClear's approach, recognizing its potential to revolutionize the industry. With their commitment to providing simple and effective technologies, TearClear is dedicated to improving patients' lives and meeting the unmet needs of eye care.

Overall, TearClear's innovative approach and dedication to patient well-being make them a sought-after brand in the field of ophthalmic drug delivery